0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Swine Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Published Date: May 2024
|
Report Code: QYRE-Auto-6J9176
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Swine Vaccines Market Outlook 2022
BUY CHAPTERS

Global Swine Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Code: QYRE-Auto-6J9176
Report
May 2024
Pages:165
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Swine Vaccines Market Size

The global Swine Vaccines market is projected to reach US$ 1820.9 million by 2030 from an estimated US$ 1439.1 million in 2024, at a CAGR of 4.0% during 2024 and 2030.

Swine Vaccines Market

Swine Vaccines Market

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Swine Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Swine Vaccines.
The Swine Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Vaccines market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation

Scope of Swine Vaccines Market Report

Report Metric Details
Report Name Swine Vaccines Market
Accounted market size in 2024 an estimated US$ 1439.1 million
Forecasted market size in 2030 US$ 1820.9 million
CAGR 4.0%
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • CSF Vaccines
  • FMD Vaccines
  • Porcine Circovirus Vaccines
  • PRRS Vaccines
  • Others
Segment by Application
  • Government Tender
  • Market Sales
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio, Chopper Biology, WINSUN, Hipra, Ringpu Biology, ChengDu Tecbond, DHN, CAVAC, Virbac, HVRI, Bioveta
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Swine Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Vaccines sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

How fast is Swine Vaccines Market growing?

Ans: The Swine Vaccines Market witnessing a CAGR of 4.0% during the forecast period 2024-2030.

What is the Swine Vaccines Market size in 2030?

Ans: The Swine Vaccines Market size in 2030 will be US$ 1820.9 million.

What is the Swine Vaccines Market share by region?

Ans: China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc.

What is the market share of major companies in Swine Vaccines Market?

Ans: Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.

Who are the main players in the Swine Vaccines Market report?

Ans: The main players in the Swine Vaccines Market are Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio, Chopper Biology, WINSUN, Hipra, Ringpu Biology, ChengDu Tecbond, DHN, CAVAC, Virbac, HVRI, Bioveta

What are the Application segmentation covered in the Swine Vaccines Market report?

Ans: The Applications covered in the Swine Vaccines Market report are Government Tender, Market Sales

What are the Type segmentation covered in the Swine Vaccines Market report?

Ans: The Types covered in the Swine Vaccines Market report are CSF Vaccines, FMD Vaccines, Porcine Circovirus Vaccines, PRRS Vaccines, Others

1 Study Coverage
1.1 Swine Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Swine Vaccines Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Others
1.3 Market by Application
1.3.1 Global Swine Vaccines Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Swine Vaccines Market Size Estimates and Forecasts
2.1.1 Global Swine Vaccines Revenue 2019-2030
2.1.2 Global Swine Vaccines Sales 2019-2030
2.2 Swine Vaccines Market Size by Region: 2023 Versus 2030
2.3 Swine Vaccines Sales by Region (2019-2030)
2.3.1 Global Swine Vaccines Sales by Region: 2019-2024
2.3.2 Global Swine Vaccines Sales Forecast by Region (2025-2030)
2.3.3 Global Swine Vaccines Sales Market Share by Region (2019-2030)
2.4 Swine Vaccines Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Swine Vaccines Revenue by Region: 2019-2024
2.4.2 Global Swine Vaccines Revenue Forecast by Region (2025-2030)
2.4.3 Global Swine Vaccines Revenue Market Share by Region (2019-2030)
3 Global Swine Vaccines by Manufacturers
3.1 Global Top Swine Vaccines Manufacturers by Sales
3.1.1 Global Swine Vaccines Sales by Manufacturer (2019-2024)
3.1.2 Global Swine Vaccines Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Swine Vaccines Manufacturers by Revenue
3.2.1 Global Swine Vaccines Revenue by Manufacturer (2019-2024)
3.2.2 Global Swine Vaccines Revenue Share by Manufacturer (2019-2024)
3.3 Global Swine Vaccines Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Swine Vaccines Manufacturers Covered: Ranking by Revenue
3.4.2 Global Swine Vaccines Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Swine Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Swine Vaccines Manufacturing Base Distribution, Product Type
3.5.1 Swine Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Swine Vaccines Product Type
3.5.3 Date of International Manufacturers Enter into Swine Vaccines Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Merck
4.1.1 Merck Company Information
4.1.2 Merck Description, Business Overview
4.1.3 Merck Swine Vaccines Products Offered
4.1.4 Merck Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Merck Swine Vaccines Sales by Product in 2023
4.1.6 Merck Swine Vaccines Sales by Application in 2023
4.1.7 Merck Swine Vaccines Sales by Geographic Area in 2023
4.1.8 Merck Recent Developments
4.2 Boehringer Ingelheim
4.2.1 Boehringer Ingelheim Company Information
4.2.2 Boehringer Ingelheim Description, Business Overview
4.2.3 Boehringer Ingelheim Swine Vaccines Products Offered
4.2.4 Boehringer Ingelheim Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Boehringer Ingelheim Swine Vaccines Sales by Product in 2023
4.2.6 Boehringer Ingelheim Swine Vaccines Sales by Application in 2023
4.2.7 Boehringer Ingelheim Swine Vaccines Sales by Geographic Area in 2023
4.2.8 Boehringer Ingelheim Recent Developments
4.3 Jinyu Bio-Technology
4.3.1 Jinyu Bio-Technology Company Information
4.3.2 Jinyu Bio-Technology Description, Business Overview
4.3.3 Jinyu Bio-Technology Swine Vaccines Products Offered
4.3.4 Jinyu Bio-Technology Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Jinyu Bio-Technology Swine Vaccines Sales by Product in 2023
4.3.6 Jinyu Bio-Technology Swine Vaccines Sales by Application in 2023
4.3.7 Jinyu Bio-Technology Swine Vaccines Sales by Geographic Area in 2023
4.3.8 Jinyu Bio-Technology Recent Developments
4.4 CAHIC
4.4.1 CAHIC Company Information
4.4.2 CAHIC Description, Business Overview
4.4.3 CAHIC Swine Vaccines Products Offered
4.4.4 CAHIC Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.4.5 CAHIC Swine Vaccines Sales by Product in 2023
4.4.6 CAHIC Swine Vaccines Sales by Application in 2023
4.4.7 CAHIC Swine Vaccines Sales by Geographic Area in 2023
4.4.8 CAHIC Recent Developments
4.5 Tecon
4.5.1 Tecon Company Information
4.5.2 Tecon Description, Business Overview
4.5.3 Tecon Swine Vaccines Products Offered
4.5.4 Tecon Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Tecon Swine Vaccines Sales by Product in 2023
4.5.6 Tecon Swine Vaccines Sales by Application in 2023
4.5.7 Tecon Swine Vaccines Sales by Geographic Area in 2023
4.5.8 Tecon Recent Developments
4.6 Zoetis
4.6.1 Zoetis Company Information
4.6.2 Zoetis Description, Business Overview
4.6.3 Zoetis Swine Vaccines Products Offered
4.6.4 Zoetis Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Zoetis Swine Vaccines Sales by Product in 2023
4.6.6 Zoetis Swine Vaccines Sales by Application in 2023
4.6.7 Zoetis Swine Vaccines Sales by Geographic Area in 2023
4.6.8 Zoetis Recent Development
4.7 Ceva
4.7.1 Ceva Company Information
4.7.2 Ceva Description, Business Overview
4.7.3 Ceva Swine Vaccines Products Offered
4.7.4 Ceva Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.7.5 Ceva Swine Vaccines Sales by Product in 2023
4.7.6 Ceva Swine Vaccines Sales by Application in 2023
4.7.7 Ceva Swine Vaccines Sales by Geographic Area in 2023
4.7.8 Ceva Recent Development
4.8 Hile Bio
4.8.1 Hile Bio Company Information
4.8.2 Hile Bio Description, Business Overview
4.8.3 Hile Bio Swine Vaccines Products Offered
4.8.4 Hile Bio Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.8.5 Hile Bio Swine Vaccines Sales by Product in 2023
4.8.6 Hile Bio Swine Vaccines Sales by Application in 2023
4.8.7 Hile Bio Swine Vaccines Sales by Geographic Area in 2023
4.8.8 Hile Bio Recent Development
4.9 Chopper Biology
4.9.1 Chopper Biology Company Information
4.9.2 Chopper Biology Description, Business Overview
4.9.3 Chopper Biology Swine Vaccines Products Offered
4.9.4 Chopper Biology Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.9.5 Chopper Biology Swine Vaccines Sales by Product in 2023
4.9.6 Chopper Biology Swine Vaccines Sales by Application in 2023
4.9.7 Chopper Biology Swine Vaccines Sales by Geographic Area in 2023
4.9.8 Chopper Biology Recent Development
4.10 WINSUN
4.10.1 WINSUN Company Information
4.10.2 WINSUN Description, Business Overview
4.10.3 WINSUN Swine Vaccines Products Offered
4.10.4 WINSUN Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.10.5 WINSUN Swine Vaccines Sales by Product in 2023
4.10.6 WINSUN Swine Vaccines Sales by Application in 2023
4.10.7 WINSUN Swine Vaccines Sales by Geographic Area in 2023
4.10.8 WINSUN Recent Development
4.11 Hipra
4.11.1 Hipra Company Information
4.11.2 Hipra Description, Business Overview
4.11.3 Hipra Swine Vaccines Products Offered
4.11.4 Hipra Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.11.5 Hipra Swine Vaccines Sales by Product in 2023
4.11.6 Hipra Swine Vaccines Sales by Application in 2023
4.11.7 Hipra Swine Vaccines Sales by Geographic Area in 2023
4.11.8 Hipra Recent Development
4.12 Ringpu Biology
4.12.1 Ringpu Biology Company Information
4.12.2 Ringpu Biology Description, Business Overview
4.12.3 Ringpu Biology Swine Vaccines Products Offered
4.12.4 Ringpu Biology Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.12.5 Ringpu Biology Swine Vaccines Sales by Product in 2023
4.12.6 Ringpu Biology Swine Vaccines Sales by Application in 2023
4.12.7 Ringpu Biology Swine Vaccines Sales by Geographic Area in 2023
4.12.8 Ringpu Biology Recent Development
4.13 ChengDu Tecbond
4.13.1 ChengDu Tecbond Company Information
4.13.2 ChengDu Tecbond Description, Business Overview
4.13.3 ChengDu Tecbond Swine Vaccines Products Offered
4.13.4 ChengDu Tecbond Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.13.5 ChengDu Tecbond Swine Vaccines Sales by Product in 2023
4.13.6 ChengDu Tecbond Swine Vaccines Sales by Application in 2023
4.13.7 ChengDu Tecbond Swine Vaccines Sales by Geographic Area in 2023
4.13.8 ChengDu Tecbond Recent Development
4.14 DHN
4.14.1 DHN Company Information
4.14.2 DHN Description, Business Overview
4.14.3 DHN Swine Vaccines Products Offered
4.14.4 DHN Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.14.5 DHN Swine Vaccines Sales by Product in 2023
4.14.6 DHN Swine Vaccines Sales by Application in 2023
4.14.7 DHN Swine Vaccines Sales by Geographic Area in 2023
4.14.8 DHN Recent Development
4.15 CAVAC
4.15.1 CAVAC Company Information
4.15.2 CAVAC Description, Business Overview
4.15.3 CAVAC Swine Vaccines Products Offered
4.15.4 CAVAC Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.15.5 CAVAC Swine Vaccines Sales by Product in 2023
4.15.6 CAVAC Swine Vaccines Sales by Application in 2023
4.15.7 CAVAC Swine Vaccines Sales by Geographic Area in 2023
4.15.8 CAVAC Recent Development
4.16 Virbac
4.16.1 Virbac Company Information
4.16.2 Virbac Description, Business Overview
4.16.3 Virbac Swine Vaccines Products Offered
4.16.4 Virbac Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.16.5 Virbac Swine Vaccines Sales by Product in 2023
4.16.6 Virbac Swine Vaccines Sales by Application in 2023
4.16.7 Virbac Swine Vaccines Sales by Geographic Area in 2023
4.16.8 Virbac Recent Development
4.17 HVRI
4.17.1 HVRI Company Information
4.17.2 HVRI Description, Business Overview
4.17.3 HVRI Swine Vaccines Products Offered
4.17.4 HVRI Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.17.5 HVRI Swine Vaccines Sales by Product in 2023
4.17.6 HVRI Swine Vaccines Sales by Application in 2023
4.17.7 HVRI Swine Vaccines Sales by Geographic Area in 2023
4.17.8 HVRI Recent Development
4.18 Bioveta
4.18.1 Bioveta Company Information
4.18.2 Bioveta Description, Business Overview
4.18.3 Bioveta Swine Vaccines Products Offered
4.18.4 Bioveta Swine Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.18.5 Bioveta Swine Vaccines Sales by Product in 2023
4.18.6 Bioveta Swine Vaccines Sales by Application in 2023
4.18.7 Bioveta Swine Vaccines Sales by Geographic Area in 2023
4.18.8 Bioveta Recent Development
5 Breakdown Data by Type
5.1 Global Swine Vaccines Sales by Type (2019-2030)
5.1.1 Global Swine Vaccines Sales by Type (2019-2024)
5.1.2 Global Swine Vaccines Sales Forecast by Type (2025-2030)
5.1.3 Global Swine Vaccines Sales Market Share by Type (2019-2030)
5.2 Global Swine Vaccines Revenue Forecast by Type (2019-2030)
5.2.1 Global Swine Vaccines Revenue by Type (2019-2024)
5.2.2 Global Swine Vaccines Revenue Forecast by Type (2025-2030)
5.2.3 Global Swine Vaccines Revenue Market Share by Type (2019-2030)
5.3 Swine Vaccines Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Swine Vaccines Sales by Application (2019-2030)
6.1.1 Global Swine Vaccines Sales by Application (2019-2024)
6.1.2 Global Swine Vaccines Sales Forecast by Application (2025-2030)
6.1.3 Global Swine Vaccines Sales Market Share by Application (2019-2030)
6.2 Global Swine Vaccines Revenue Forecast by Application (2019-2030)
6.2.1 Global Swine Vaccines Revenue by Application (2019-2024)
6.2.2 Global Swine Vaccines Revenue Forecast by Application (2025-2030)
6.2.3 Global Swine Vaccines Revenue Market Share by Application (2019-2030)
6.3 Swine Vaccines Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Swine Vaccines Market Size YoY Growth 2019-2030
7.2 North America Swine Vaccines Market Facts & Figures by Country
7.2.1 North America Swine Vaccines Sales by Country (2019-2030)
7.2.2 North America Swine Vaccines Revenue by Country (2019-2030)
7.3 North America Swine Vaccines Sales by Type (2019-2024)
7.4 North America Swine Vaccines Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Swine Vaccines Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Swine Vaccines Market Facts & Figures by Region
8.2.1 Asia-Pacific Swine Vaccines Sales by Region (2019-2030)
8.2.2 Asia-Pacific Swine Vaccines Revenue by Region (2019-2030)
8.3 Asia-Pacific Swine Vaccines Sales by Type (2019-2024)
8.4 Asia-Pacific Swine Vaccines Sales by Application (2019-2024)
9 Europe
9.1 Europe Swine Vaccines Market Size YoY Growth 2019-2030
9.2 Europe Swine Vaccines Market Facts & Figures by Country
9.2.1 Europe Swine Vaccines Sales by Country (2019-2030)
9.2.2 Europe Swine Vaccines Revenue by Country (2019-2030)
9.3 Europe Swine Vaccines Sales by Type (2019-2024)
9.4 Europe Swine Vaccines Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Swine Vaccines Market Size YoY Growth 2019-2030
10.2 Latin America Swine Vaccines Market Facts & Figures by Country
10.2.1 Latin America Swine Vaccines Sales by Country (2019-2030)
10.2.2 Latin America Swine Vaccines Revenue by Country (2019-2030)
10.3 Latin America Swine Vaccines Sales by Type (2019-2024)
10.4 Latin America Swine Vaccines Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Swine Vaccines Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Swine Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Swine Vaccines Sales by Country (2019-2030)
11.2.2 Middle East and Africa Swine Vaccines Revenue by Country (2019-2030)
11.3 Middle East and Africa Swine Vaccines Sales by Type (2019-2024)
11.4 Middle East and Africa Swine Vaccines Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Swine Vaccines Supply Chain Analysis
12.2 Swine Vaccines Key Raw Materials and Upstream Suppliers
12.3 Swine Vaccines Clients Analysis
12.4 Swine Vaccines Sales Channel and Sales Model Analysis
12.4.1 Swine Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Swine Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Swine Vaccines Distributors
13 Market Dynamics
13.1 Swine Vaccines Industry Trends
13.2 Swine Vaccines Market Drivers
13.3 Swine Vaccines Market Challenges
13.4 Swine Vaccines Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Swine Vaccines Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Major Manufacturers of CSF Vaccines
    Table 3. Major Manufacturers of FMD Vaccines
    Table 4. Major Manufacturers of Porcine Circovirus Vaccines
    Table 5. Major Manufacturers of PRRS Vaccines
    Table 6. Major Manufacturers of Others
    Table 7. Global Swine Vaccines Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Swine Vaccines Market Size by Region (US$ Million): 2023 VS 2030
    Table 9. Global Swine Vaccines Sales by Region (2019-2024) & (M Doses)
    Table 10. Global Swine Vaccines Sales Forecast by Region (2025-2030) & (M Doses)
    Table 11. Global Swine Vaccines Revenue by Region (2019-2024) & (US$ Million)
    Table 12. Global Swine Vaccines Revenue Forecast by Region (2025-2030) & (US$ Million)
    Table 13. Global Swine Vaccines Sales by Manufacturer (2019-2024) & (M Doses)
    Table 14. Global Swine Vaccines Sales Share by Manufacturer (2019-2024)
    Table 15. Swine Vaccines Revenue by Manufacturer (2019-2024) & (US$ Million)
    Table 16. Swine Vaccines Revenue Share by Manufacturer (2019-2024)
    Table 17. Key Manufacturers Swine Vaccines Price (2019-2024) & (USD/K Doses)
    Table 18. Ranking of Global Top Swine Vaccines Manufacturers by Revenue (US$ Million) in 2023
    Table 19. Global Swine Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)
    Table 20. Global Swine Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swine Vaccines as of 2023)
    Table 21. Swine Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Swine Vaccines Product Type
    Table 23. Date of International Manufacturers Enter into Swine Vaccines Market
    Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 25. Merck Company Information
    Table 26. Merck Description and Business Overview
    Table 27. Merck Swine Vaccines Product
    Table 28. Merck Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 29. Merck Sales Proportion of Swine Vaccines by Product in 2023
    Table 30. Merck Sales Proportion of Swine Vaccines by Application in 2023
    Table 31. Merck Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 32. Merck Recent Development
    Table 33. Boehringer Ingelheim Company Information
    Table 34. Boehringer Ingelheim Description and Business Overview
    Table 35. Boehringer Ingelheim Swine Vaccines Product
    Table 36. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 37. Boehringer Ingelheim Sales Proportion of Swine Vaccines by Product in 2023
    Table 38. Boehringer Ingelheim Sales Proportion of Swine Vaccines by Application in 2023
    Table 39. Boehringer Ingelheim Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 40. Boehringer Ingelheim Recent Development
    Table 41. Jinyu Bio-Technology Company Information
    Table 42. Jinyu Bio-Technology Description and Business Overview
    Table 43. Jinyu Bio-Technology Swine Vaccines Product
    Table 44. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 45. Jinyu Bio-Technology Sales Proportion of Swine Vaccines by Product in 2023
    Table 46. Jinyu Bio-Technology Sales Proportion of Swine Vaccines by Application in 2023
    Table 47. Jinyu Bio-Technology Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 48. Jinyu Bio-Technology Recent Development
    Table 49. CAHIC Company Information
    Table 50. CAHIC Description and Business Overview
    Table 51. CAHIC Swine Vaccines Product
    Table 52. CAHIC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 53. CAHIC Sales Proportion of Swine Vaccines by Product in 2023
    Table 54. CAHIC Sales Proportion of Swine Vaccines by Application in 2023
    Table 55. CAHIC Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 56. CAHIC Recent Development
    Table 57. Tecon Company Information
    Table 58. Tecon Description and Business Overview
    Table 59. Tecon Swine Vaccines Product
    Table 60. Tecon Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 61. Tecon Sales Proportion of Swine Vaccines by Product in 2023
    Table 62. Tecon Sales Proportion of Swine Vaccines by Application in 2023
    Table 63. Tecon Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 64. Tecon Recent Development
    Table 65. Zoetis Company Information
    Table 66. Zoetis Description and Business Overview
    Table 67. Zoetis Swine Vaccines Product
    Table 68. Zoetis Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 69. Zoetis Sales Proportion of Swine Vaccines by Product in 2023
    Table 70. Zoetis Sales Proportion of Swine Vaccines by Application in 2023
    Table 71. Zoetis Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 72. Zoetis Recent Development
    Table 73. Ceva Company Information
    Table 74. Ceva Description and Business Overview
    Table 75. Ceva Swine Vaccines Product
    Table 76. Ceva Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 77. Ceva Sales Proportion of Swine Vaccines by Product in 2023
    Table 78. Ceva Sales Proportion of Swine Vaccines by Application in 2023
    Table 79. Ceva Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 80. Ceva Recent Development
    Table 81. Hile Bio Company Information
    Table 82. Hile Bio Description and Business Overview
    Table 83. Hile Bio Swine Vaccines Product
    Table 84. Hile Bio Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 85. Hile Bio Sales Proportion of Swine Vaccines by Product in 2023
    Table 86. Hile Bio Sales Proportion of Swine Vaccines by Application in 2023
    Table 87. Hile Bio Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 88. Hile Bio Recent Development
    Table 89. Chopper Biology Company Information
    Table 90. Chopper Biology Description and Business Overview
    Table 91. Chopper Biology Swine Vaccines Product
    Table 92. Chopper Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 93. Chopper Biology Sales Proportion of Swine Vaccines by Product in 2023
    Table 94. Chopper Biology Sales Proportion of Swine Vaccines by Application in 2023
    Table 95. Chopper Biology Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 96. Chopper Biology Recent Development
    Table 97. WINSUN Company Information
    Table 98. WINSUN Description and Business Overview
    Table 99. WINSUN Swine Vaccines Product
    Table 100. WINSUN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 101. WINSUN Sales Proportion of Swine Vaccines by Product in 2023
    Table 102. WINSUN Sales Proportion of Swine Vaccines by Application in 2023
    Table 103. WINSUN Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 104. WINSUN Recent Development
    Table 105. Hipra Company Information
    Table 106. Hipra Description and Business Overview
    Table 107. Hipra Swine Vaccines Product
    Table 108. Hipra Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 109. Hipra Sales Proportion of Swine Vaccines by Product in 2023
    Table 110. Hipra Sales Proportion of Swine Vaccines by Application in 2023
    Table 111. Hipra Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 112. Hipra Recent Development
    Table 113. Ringpu Biology Company Information
    Table 114. Ringpu Biology Description and Business Overview
    Table 115. Ringpu Biology Swine Vaccines Product
    Table 116. Ringpu Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 117. Ringpu Biology Sales Proportion of Swine Vaccines by Product in 2023
    Table 118. Ringpu Biology Sales Proportion of Swine Vaccines by Application in 2023
    Table 119. Ringpu Biology Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 120. Ringpu Biology Recent Development
    Table 121. ChengDu Tecbond Company Information
    Table 122. ChengDu Tecbond Description and Business Overview
    Table 123. ChengDu Tecbond Swine Vaccines Product
    Table 124. ChengDu Tecbond Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 125. ChengDu Tecbond Sales Proportion of Swine Vaccines by Product in 2023
    Table 126. ChengDu Tecbond Sales Proportion of Swine Vaccines by Application in 2023
    Table 127. ChengDu Tecbond Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 128. ChengDu Tecbond Recent Development
    Table 129. DHN Company Information
    Table 130. DHN Description and Business Overview
    Table 131. DHN Swine Vaccines Product
    Table 132. DHN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 133. DHN Sales Proportion of Swine Vaccines by Product in 2023
    Table 134. DHN Sales Proportion of Swine Vaccines by Application in 2023
    Table 135. DHN Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 136. DHN Recent Development
    Table 137. CAVAC Company Information
    Table 138. CAVAC Description and Business Overview
    Table 139. CAVAC Swine Vaccines Product
    Table 140. CAVAC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 141. CAVAC Sales Proportion of Swine Vaccines by Product in 2023
    Table 142. CAVAC Sales Proportion of Swine Vaccines by Application in 2023
    Table 143. CAVAC Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 144. CAVAC Recent Development
    Table 145. Virbac Company Information
    Table 146. Virbac Description and Business Overview
    Table 147. Virbac Swine Vaccines Product
    Table 148. Virbac Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 149. Virbac Sales Proportion of Swine Vaccines by Product in 2023
    Table 150. Virbac Sales Proportion of Swine Vaccines by Application in 2023
    Table 151. Virbac Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 152. Virbac Recent Development
    Table 153. HVRI Company Information
    Table 154. HVRI Description and Business Overview
    Table 155. HVRI Swine Vaccines Product
    Table 156. HVRI Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 157. HVRI Sales Proportion of Swine Vaccines by Product in 2023
    Table 158. HVRI Sales Proportion of Swine Vaccines by Application in 2023
    Table 159. HVRI Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 160. HVRI Recent Development
    Table 161. Bioveta Company Information
    Table 162. Bioveta Description and Business Overview
    Table 163. Bioveta Swine Vaccines Product
    Table 164. Bioveta Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 165. Bioveta Sales Proportion of Swine Vaccines by Product in 2023
    Table 166. Bioveta Sales Proportion of Swine Vaccines by Application in 2023
    Table 167. Bioveta Sales Proportion of Swine Vaccines by Geographic Area in 2023
    Table 168. Bioveta Recent Development
    Table 169. Global Swine Vaccines Sales by Type (2019-2024) & (M Doses)
    Table 170. Global Swine Vaccines Sales Forecast by Type (2025-2030) & (M Doses)
    Table 171. Global Swine Vaccines Revenue by Type (2019-2024) & (US$ Million)
    Table 172. Global Swine Vaccines Revenue Forecast by Type (2025-2030) & (US$ Million)
    Table 173. Global Swine Vaccines Sales by Application (2019-2024) & (M Doses)
    Table 174. Global Swine Vaccines Sales Forecast by Application (2025-2030) & (M Doses)
    Table 175. Global Swine Vaccines Revenue by Application (2019-2024) & (US$ Million)
    Table 176. Global Swine Vaccines Revenue Forecast by Application (2025-2030) & (US$ Million)
    Table 177. North America Swine Vaccines Sales by Country (2019-2024) & (M Doses)
    Table 178. North America Swine Vaccines Sales by Country (2025-2030) & (M Doses)
    Table 179. North America Swine Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 180. North America Swine Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 181. North America Swine Vaccines Sales by Type (2019-2024) & (M Doses)
    Table 182. North America Swine Vaccines Sales by Application (2019-2024) & (M Doses)
    Table 183. Asia-Pacific Swine Vaccines Sales by Region (2019-2024) & (M Doses)
    Table 184. Asia-Pacific Swine Vaccines Sales by Region (2025-2030) & (M Doses)
    Table 185. Asia-Pacific Swine Vaccines Revenue by Region (2019-2030) & (US$ Million)
    Table 186. Asia-Pacific Swine Vaccines Revenue by Region (2025-2030) & (US$ Million)
    Table 187. Asia-Pacific Swine Vaccines Sales by Type (2019-2024) & (M Doses)
    Table 188. Asia-Pacific Swine Vaccines Sales by Application (2019-2024) & (M Doses)
    Table 189. Europe Swine Vaccines Sales by Country (2019-2024) & (M Doses)
    Table 190. Europe Swine Vaccines Sales by Country (2025-2030) & (M Doses)
    Table 191. Europe Swine Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 192. Europe Swine Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 193. Europe Swine Vaccines Sales by Type (2019-2024) & (M Doses)
    Table 194. Europe Swine Vaccines Sales by Application (2019-2024) & (M Doses)
    Table 195. Latin America Swine Vaccines Sales by Country (2019-2024) & (M Doses)
    Table 196. Latin America Swine Vaccines Sales by Country (2025-2030) & (M Doses)
    Table 197. Latin America Swine Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 198. Latin America Swine Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 199. Latin America Swine Vaccines Sales by Type (2019-2024) & (M Doses)
    Table 200. Latin America Swine Vaccines Sales by Application (2019-2024) & (M Doses)
    Table 201. Middle East and Africa Swine Vaccines Sales by Country (2019-2024) & (M Doses)
    Table 202. Middle East and Africa Swine Vaccines Sales by Country (2025-2030) & (M Doses)
    Table 203. Middle East and Africa Swine Vaccines Revenue by Country (2019-2024) & (US$ Million)
    Table 204. Middle East and Africa Swine Vaccines Revenue by Country (2025-2030) & (US$ Million)
    Table 205. Middle East and Africa Swine Vaccines Sales by Type (2019-2024) & (M Doses)
    Table 206. Middle East and Africa Swine Vaccines Sales by Application (2019-2024) & (M Doses)
    Table 207. Swine Vaccines Key Raw Materials, Industry Status and Trend
    Table 208. Swine Vaccines Key Raw Materials and Upstream Suppliers
    Table 209. Swine Vaccines Clients Status and Trend
    Table 210. Swine Vaccines Typical Clients
    Table 211. Swine Vaccines Distributors
    Table 212. Swine Vaccines Market Trends
    Table 213. Swine Vaccines Market Drivers
    Table 214. Swine Vaccines Market Challenges
    Table 215. Swine Vaccines Market Restraints
    Table 216. Research Programs/Design for This Report
    Table 217. Key Data Information from Secondary Sources
    Table 218. Key Data Information from Primary Sources
List of Figures
    Figure 1. Swine Vaccines Product Picture
    Figure 2. Global Swine Vaccines Sales Market Share by Type in 2023 & 2030
    Figure 3. CSF Vaccines Product Picture
    Figure 4. FMD Vaccines Product Picture
    Figure 5. Porcine Circovirus Vaccines Product Picture
    Figure 6. PRRS Vaccines Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Swine Vaccines Sales Market Share by Application in 2023 & 2030
    Figure 9. Government Tender Examples
    Figure 10. Market Sales Examples
    Figure 11. Swine Vaccines Report Years Considered
    Figure 12. Global Swine Vaccines Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Swine Vaccines Market Size 2019-2030 (US$ Million)
    Figure 14. Global Swine Vaccines Sales 2019-2030 (M Doses)
    Figure 15. Global Swine Vaccines Sales Market Share Forecast by Region (2019-2030)
    Figure 16. Global Swine Vaccines Revenue Market Share by Region (2019-2030)
    Figure 17. Global Swine Vaccines Sales Share by Manufacturer in 2023
    Figure 18. Swine Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Swine Vaccines Sales Market Share Forecast by Type (2019-2030)
    Figure 20. Global Swine Vaccines Revenue Market Share Forecast by Type (2019-2030)
    Figure 21. Swine Vaccines Average Selling Price (ASP) by Type (2019-2024) & (USD/K Doses)
    Figure 22. Global Swine Vaccines Sales Market Share Forecast by Application (2019-2030)
    Figure 23. Global Swine Vaccines Revenue Market Share Forecast by Application (2019-2030)
    Figure 24. Swine Vaccines Average Selling Price (ASP) by Application (2019-2024) & (USD/K Doses)
    Figure 25. North America Swine Vaccines Revenue 2019-2030 (US$ Million)
    Figure 26. North America Swine Vaccines Sales Market Share by Type (2019-2024)
    Figure 27. North America Swine Vaccines Sales Market Share by Application (2019-2024)
    Figure 28. Asia-Pacific Swine Vaccines Revenue 2019-2030 (US$ Million)
    Figure 29. Asia-Pacific Swine Vaccines Sales Market Share by Region (2019-2030)
    Figure 30. Asia-Pacific Swine Vaccines Revenue Market Share by Region (2019-2030)
    Figure 31. Asia-Pacific Swine Vaccines Sales Market Share by Type (2019-2024)
    Figure 32. Asia-Pacific Swine Vaccines Sales Market Share by Application (2019-2024)
    Figure 33. Europe Swine Vaccines Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 34. Europe Swine Vaccines Sales Market Share by Country (2019-2030)
    Figure 35. Europe Swine Vaccines Revenue Market Share by Country (2019-2030)
    Figure 36. Europe Swine Vaccines Sales Market Share by Type (2019-2024)
    Figure 37. Europe Swine Vaccines Sales Market Share by Application (2019-2024)
    Figure 38. Latin America Swine Vaccines Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 39. Latin America Swine Vaccines Sales Market Share by Country (2019-2030)
    Figure 40. Latin America Swine Vaccines Revenue Market Share by Country (2019-2024)
    Figure 41. Latin America Swine Vaccines Sales Market Share by Type (2019-2024)
    Figure 42. Latin America Swine Vaccines Sales Market Share by Application (2019-2024)
    Figure 43. Middle East and Africa Swine Vaccines Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 44. Middle East and Africa Swine Vaccines Sales Market Share by Country (2019-2030)
    Figure 45. Middle East and Africa Swine Vaccines Revenue Market Share by Country (2019-2030)
    Figure 46. Middle East and Africa Swine Vaccines Sales Market Share by Type (2019-2024)
    Figure 47. Middle East and Africa Swine Vaccines Sales Market Share by Application (2019-2024)
    Figure 48. Swine Vaccines Supply Chain (Upstream and Downstream Market)
    Figure 49. Global Production Market Share of Swine Vaccines Raw Materials by Region in 2023
    Figure 50. Swine Vaccines Distribution Channels
    Figure 51. Global Swine Vaccines Percentage 2019-2030: Indirect Sales VS Direct Sales
    Figure 52. Global Swine Vaccines Percentage 2019-2030: Online Sales VS Offline Sales
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS